Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Baxter International Initiates Phase III Autologous Stem Cell Clinical Trial to Improve Patients with CMI

Posted by taylor@stemsave.com on Mar 30, 2012 3:28:02 PM

Baxter International Inc. has initiated a phase III pivotal clinical trial to evaluate the use of adult autologous (an individual's own) stem cells to increase exercise capacity in patients who suffer from chronic myocardial ischemia (CMI), a disease that results in reduced blood supply to the heart that can lead to long-term tissue damage and heart failure.

Read More

Topics: CMI, stemsaveblog, chronic myocardial ischemia, Baxter International Inc, Baxter International

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all